Atara Biotherapeutics, Inc.
ATRA
$9.91
-$0.32-3.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.83M | -4.15M | -3.41M | -4.30M | 2.39M |
| Total Depreciation and Amortization | 14.00K | 29.00K | 1.05M | -964.00K | 236.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 780.00K | 1.80M | -1.37M | 3.36M | 2.83M |
| Change in Net Operating Assets | 702.00K | -754.00K | -1.97M | -7.88M | -12.77M |
| Cash from Operations | -3.34M | -3.07M | -5.70M | -9.79M | -7.32M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 555.00K | 44.00K | 349.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.63M | -- | 7.89M | -2.47M | -5.42M |
| Cash from Investing | -6.63M | -- | 8.44M | -2.42M | -5.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 4.83M | 2.95M | 14.84M | 1.51M | 1.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -14.84M | -461.00K | 15.30M |
| Cash from Financing | 4.83M | 2.95M | -3.00K | 1.05M | 15.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.14M | -122.00K | 2.74M | -11.16M | 2.92M |